Month: January 2022

New Study Finds Merck Cancer Drug Keytruda May Target HIV

Researchers studying Merck & Co Inc’s cancer drug Keytruda for HIV patients who also have cancer say the immunotherapy may help displace the virus from human immune cells, offering an intriguing area of study for treatment of chronic HIV infection.Antiretroviral treatments… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a […]

Published on January 27, 2022

How COVID Testing, Isolation Will Work at Olympics

Athletes and others headed to the Olympics face a multitude of COVID-19 testing hurdles as organizers seek to catch any infections early and keep the virus at bay. A positive test could mean athletes sitting out the Beijing Games – perhaps even if they’re no longer… Read Full Article (External Site) Dr. David LowemannDr. David […]

Published on January 27, 2022

Booster Shot Cuts Omicron Death Risk by 95 Percent: UK Study

COVID-19 boosters increase protection against death from the omicron variant to 95% in people aged 50 or over, the UK Health Security Agency said on Thursday. The UKHSA said that around six months after a second dose of any of the COVID-19 vaccines, protection against death… Read Full Article (External Site) Dr. David LowemannDr. David […]

Published on January 27, 2022